How to buy imported Acotiamide

Acotiamide (Acotiamide) was first launched in Japan in 2013 under the trade name "Acofide" and is produced by Japan's Zeria Pharmaceutical Company. The drug was subsequently marketed in Russia under the name of a drug with the same ingredients. At present, acotiamide has not been officially approved for marketing in mainland China, nor has it been included in the national medical insurance directory. Therefore, if domestic patients want to use the drug, they can only purchase it legally through overseas channels, such as through cross-border e-commerce or overseas pharmacy platforms after obtaining a doctor's prescription.

In the Japanese market, the common specification of acotiamide is 100 mg × 100 tablets/box. Patients usually need to take it orally three times a day, 100 mg each time, before meals. The specifications of the Russian version of drugs are basically the same as those of the Japanese version, and the drug quality standards also meet the requirements of the International Pharmacopoeia. According to data from overseas drug information websites, the price of the drug in Japanese pharmacies is about RMB 2,000, while the price in Russian pharmacies may be slightly lower. The specific price will fluctuate due to exchange rate changes and transportation costs.

When purchasing imported acotiamide, you need to pay attention to the legality of the channel and the authenticity of the drug. It is recommended to place orders through regular pharmacy websites with international drug circulation qualifications and avoid purchasing through platforms from unknown sources to prevent the purchase of counterfeit drugs or drugs with substandard storage and transportation conditions. The international medical departments of some domestic tertiary hospitals may also assist patients in applying for temporary imported drugs, but the process is relatively strict.

Although acotiamide is not marketed in China, its long-term use experience in Japan shows that the drug is well tolerated and the incidence of side effects is low. For patients with refractory functional dyspepsia, if conventional treatments are ineffective, they may consider applying for import under the guidance of a doctor.

Reference: https://www.rad-ar.or.jp/siori/english/search/result?n=33322